Herbert Noack
Boehringer Ingelheim (Germany)(DE)
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management, Cardiac Arrhythmias and Treatments, Antiplatelet Therapy and Cardiovascular Diseases, Acute Myocardial Infarction Research
Most-Cited Works
- → Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure(2014)229 cited
- → A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: The Randomized, phase II study to Evaluate the sAfety and pharmacokinetics of oraL dabIGatran etexilate in patients after heart valve replacemeNt (RE-ALIGN)(2012)188 cited
- → Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease(2016)165 cited
- → Treatments for stroke prevention in atrial fibrillation: A network meta-analysis and indirect comparisons versus dabigatran etexilate(2010)111 cited
- → Patient outcomes using the European label for dabigatran(2013)102 cited
- → Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies(2013)91 cited
- → Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial(2015)91 cited
- → Are large optic nerve heads susceptible to glaucomatous damage at normal intraocular pressure?(1992)87 cited
- → Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation(2012)72 cited
- → Anticoagulant-related gastrointestinal bleeding—could this facilitate early detection of benign or malignant gastrointestinal lesions?(2014)64 cited